BioMérieux
Numerous technologies in development to help with the diagnosis of sepsis have a singular objective ─ detect the condition as quickly as possible.
Becton Dickinson, Siemens Healthineers, Abbott Laboratories, Others Nab FDA Clearances in November
BioMérieux obtained FDA clearance for a multiplex RT-PCR assay that detects SARS-CoV-2 RNA in nasopharyngeal swabs from symptomatic individuals.
Ortho Clinical Diagnostics, Siemens Healthineers, Roche, and Others Obtain FDA Clearances in October
The FDA granted clearance to Roche for use of its Cobas Cdiff nucleic acid test, which detects the toxin B gene running on the firm's Liat point-of-care instrument.
BioMérieux, Baxter Get CE Mark for Acute Kidney Injury Test
The immunofluorescence test detects a biomarker in a patient's urine to predict persistent severe acute kidney injury.
Roche, Thermo Fisher Scientific, DiaSorin, BioMérieux, and Others Obtain FDA Clearances in September
Roche obtained clearance for a modification, which decreases inference to biotin, to its cleared Elecsys Troponin T Gen 5 immunoassay for myocardial infarction.
Sep 3, 2021
Sep 1, 2021
BioMérieux H1 Revenues Rise 7 Percent
Aug 20, 2021
Feb 24, 2021